Best Chemotherapy For Prostate Cancer Doctors Abroad for Australian Patients

Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in Texas – consistently ranked as one of the world's leading oncology hospitals.

• Specialises in administering hormone therapy and systemic chemotherapy for prostate cancer
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Uses targeted therapy and immunotherapy to treat advanced malignancies
• Focuses on evidence-based protocols for complex solid tumours
• Practices at the JCI-accredited Hisar Hospital Intercontinental in Istanbul

Professor Sezer Sağlam is a highly senior medical oncologist at Gayrettepe Florence Nightingale Hospital with a focus on complex drug therapies. He holds a professorship in medical oncology and manages treatment protocols for various advanced solid tumours.

• Trained at Istanbul University, one of Turkey's most prestigious medical institutions
• Member of the American Society of Clinical Oncology (ASCO)
• Full member of the European Society for Medical Oncology (ESMO)
• Specialises in neuroendocrine tumours and gastrointestinal oncology
• Collaborates with the European Neuroendocrine Tumour Society (ENET)

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Yesim Yildirim is an ESMO-certified medical oncologist who specialises in targeted therapies and immunotherapy for complex urological cancers. She practices at Anadolu Medical Center, an institution closely affiliated with the prestigious Johns Hopkins Medicine.

• Completed advanced immuno-oncology training at Mount Vernon Cancer Centre in the UK
• Specialises in targeted therapies that attack specific cancer markers while protecting healthy tissue
• Recognised as a Professor with over 80 scientific publications in international medical journals
• Member of the American Society of Clinical Oncology (ASCO)
• Full member of the European Society for Medical Oncology (ESMO)

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with high-level academic standing in complex cancer care.

• Holds the title of Professor of Medical Oncology since April 2016
• Specialises in gastrointestinal oncology and systemic treatments for advanced prostate cases
• Fellowship trained at Istanbul University Oncology Institute
• Active member of the American Society of Clinical Oncology (ASCO)
• Maintains international standards through membership in the European Society for Medical Oncology

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital, a major Turkish centre for research and clinical care.

• Promoted to Associate Professor in 2016 for his expertise in oncology
• Former physician at Erzurum Regional Training and Research Hospital
• Built clinical experience at the Ankara Oncology Clinic in Turkey
• Specialises in treating complex gastrointestinal and solid tumours

Professor Cemil Bilir focuses on the intersection of oncology and biotechnology to provide targeted cancer care at VM Medical Park Pendik Hospital.

• Completed a research fellowship at the Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Published extensive research on inorganic chemistry and pharmaceutical biotechnology protocols
• Maintains professional membership with the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Serves as a senior Professor at Sakarya University Faculty of Medicine

Dr Mustafa Serkan Alemdar is a dual-specialist in internal medicine and medical oncology at the JCI-accredited Medical Park Antalya Hospital Complex.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Expertise includes complex medication management and tailored chemotherapy protocols
• Active member of the Turkish Society of Medical Oncology
• Experienced in treating tumours at a major regional training and research hospital
• Focuses on evidence-based systemic therapies for advanced urological cancers

Professor Ercan Ozden is a dual-specialist in internal medicine and medical oncology at VM Medical Park Pendik Hospital. He manages chemotherapy protocols for complex prostate cancer cases using evidence-based medical oncology standards.

• Specialised in medical oncology at Kocaeli University Faculty of Medicine
• Completed his primary medical degree through the English Medical Programme at Istanbul University
• Holds extensive experience in internal medicine, providing a holistic approach to cancer care
• Focuses on systemic treatments and targeted therapies for urological cancers

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at Istinye University Liv Hospital Topkapi, specialising in tailored chemotherapy protocols.

• Serves as the Education Coordinator for medical oncology, training the next generation of cancer specialists
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Expert in biomarker-driven therapy, having published research on new markers for urological cancer metastasis
• Regular contributor to peer-reviewed international journals on chemotherapy survival outcomes